Maurizio Taglialatela
St George's University Of London
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Molecular Basis for Activation to Inhibition Switching in Kv7.2 Channel Modulators.
Journal: Angewandte Chemie (International ed. in English)
Published: February 21, 2026
Early sodium channel blocker initiation is associated with better outcomes in KCNQ2 disorders.
Journal: Brain : a journal of neurology
Published: October 17, 2025
Two-step voltage-sensor activation of the human KV7.4 channel and effect of a deafness-associated mutation.
Journal: Nature communications
Published: August 20, 2025
Drug enteric metabolism in gut microbiota-brain crosstalk.
Journal: Life sciences
Published: July 30, 2025
Kv7.2 loss-of-function causes early hyperexcitability and network remodelling.
Journal: Brain : a journal of neurology
Published: July 24, 2025
Optimising pediatric paracetamol and ibuprofen use: a retrospective study with expert evaluation of efficacy, safety, and healthcare costs.
Journal: Global & regional health technology assessment
Published: June 09, 2025
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis.
Journal: Cell communication and signaling : CCS
Published: March 03, 2025
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis.
Journal: Cell communication and signaling : CCS
Published: March 03, 2025
The fast-dissociating D2 antagonist antipsychotic JNJ-37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment.
Journal: British journal of pharmacology
Published: December 23, 2024
Constitutive opening of the Kv7.2 pore activation gate causes KCNQ2-developmental encephalopathy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 27, 2024
Last Updated: 09/26/2026